NCT07754578
DOSE-UP: Dose Optimization for Smoking and E-Cigarette Use Pharmacotherapy
StatusRecruiting
PhasePhase 2
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Recruitment opened
- Start date pushed from Nov 1, 2026 to Nov 17, 2026
- Site details revised
- Notable Eligibility criteria expanded, about 12 words
- Start date: Oct 10, 2026 to Nov 1, 2026
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Dual use abstinence
Timeframe: Week 12, Week 24
Cigarette abstinence
Timeframe: Weeks 12, Week 24
Arms and interventions
Behavioral SupportActive comparator
Participants will receive behavioral support only.
Standard dose NRTExperimental
Participants will receive a standard dose of nicotine replacement therapy (NRT).
High dose NRTExperimental
Participants will receive a higher dose of NRT than what is typically used.
Behavioral: Text- and web-based support
Drugs: Nicotine Replacement Therapy (NRT, nicotine patch), Nicotine replacement therapy lozenge
Sites
1 site in 1 country
- Medical University of South CarolinaCharleston, South Carolina, United States